Takeda Pharmaceutical Company Limited (FRA:TKDA)

FRA:TKDA Ratios and Metrics

Market cap in millions EUR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 26, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	45,160	41,702	40,227	46,820	40,204	47,993
Market Cap Growth	11.94%	3.67%	-14.08%	16.45%	-16.23%	10.12%
Enterprise Value	71,165	72,212	70,368	75,247	67,122	83,681
Last Close Price	14.20	13.44	12.17	13.46	11.45	13.86
PE Ratio	73.62	62.54	45.57	21.33	23.57	16.57
PS Ratio	1.86	1.47	1.54	1.68	1.52	1.95
PB Ratio	1.09	0.97	0.90	1.06	0.95	1.20
P/FCF Ratio	8.23	7.88	12.14	8.08	5.42	6.92
P/OCF Ratio	6.99	6.39	9.16	6.92	4.83	6.16
EV/Sales Ratio	2.92	2.55	2.69	2.70	2.54	3.40
EV/EBITDA Ratio	9.87	9.48	10.04	8.46	7.65	11.04
EV/EBIT Ratio	21.73	20.76	22.99	17.54	15.09	25.62
EV/FCF Ratio	12.96	13.65	21.23	12.99	9.06	12.07
Debt / Equity Ratio	0.71	0.73	0.75	0.77	0.85	0.98
Debt / EBITDA Ratio	4.09	3.96	4.57	3.79	4.07	5.16
Debt / FCF Ratio	5.37	5.94	10.10	5.81	4.81	5.64
Asset Turnover	0.29	0.31	0.29	0.30	0.27	0.25
Inventory Turnover	1.16	1.30	1.30	1.36	1.40	1.34
Quick Ratio	0.54	0.44	0.50	0.49	0.73	1.00
Current Ratio	1.19	1.01	1.11	0.97	1.21	1.53
Return on Equity (ROE)	1.50%	1.52%	2.12%	5.27%	4.24%	7.60%
Return on Assets (ROA)	2.47%	2.40%	2.15%	2.85%	2.88%	2.06%
Return on Invested Capital (ROIC)	2.76%	2.91%	4.35%	5.15%	4.82%	4.50%
Return on Capital Employed (ROCE)	4.70%	4.80%	3.90%	5.40%	5.40%	3.80%
Earnings Yield	1.36%	1.60%	2.20%	4.69%	4.24%	6.04%
FCF Yield	12.16%	12.69%	8.24%	12.37%	18.44%	14.44%
Dividend Yield	3.64%	9.01%	9.47%	9.26%	11.65%	10.00%
Payout Ratio	277.04%	280.28%	199.34%	88.14%	123.30%	75.36%
Buyback Yield / Dilution	-0.25%	-1.58%	-0.67%	0.46%	-0.23%	-0.47%
Total Shareholder Return	3.39%	7.43%	8.80%	9.72%	11.42%	9.53%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.